ArticleInternational dental journal2026
Liposomal Salvianolic Acid B Enhances ALA-PDT in Oral Leucoplakia via ROS and AKT/mTOR Signalling.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salvianolic acid B (SalB), a major component of Danshen, the ancient Chinese herb Salvia miltiorrhiza Bunge, has demonstrated inhibitory effects against various solid tumours. Our previous study explored a SalB-loaded nanocarrier as a photosensitizing formulation for photodynamic therapy (PDT) in vitro in oral leucoplakia (OLK) and oral cancer cells. This study aims to explore the underlying mechanisms and in vivo effects. In this study, different concentrations of SalB and 5-aminolevulinic acid (ALA) were incorporated into liposomes to synthesize the nano-photosensitizer (nano-SalB-ALA). Reactive oxygen species (ROS) levels in Cal27 and Leuk1 cells were evaluated by DCFH-DA staining, and the intracellular distribution of fluorescently labelled liposomes was visualized by confocal laser scanning microscopy (CLSM). Western blot was used to analyse the expression of PI3K/AKT/mTOR signalling proteins. In addition, a 4NQO-induced OLK mouse model was used to evaluate in vivo effects. Based on the most obvious intracellular ROS fluorescence signals and the greatest reduction in PI3K/AKT/mTOR signalling pathway expression observed in the nano-SalB
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.